US Patent 9868729 Inhibitors of protein kinases
Patent 9868729 was granted and assigned to Portola Pharmaceuticals on January, 2018 by the United States Patent and Trademark Office.
All edits
Edits on 7 Dec, 2023
Golden AI
Edits made to:
Article (+154 characters)
Article
Patent abstract
Provided are methods of treating inflammatory disorders, autoimmune disorders, or a hematological malignancies using compounds of formula I
Edits on 1 Oct, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Anjali Pandey0
Shawn M. Bauer0
Edits on 2 Aug, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 31 May, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09868729 Inhibitors of protein kinases US Patent 9868729 Inhibitors of protein kinases
Infobox
Patent Number
09868729
Patent Number
9868729
Edits on 16 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 09868729 Inhibitors of protein kinases
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
09868729
Date of patent
January 16, 2018
Patent application number
14561821
Date Filed
December 5, 2014
Patent primary examiner
Find more entities like US Patent 9868729 Inhibitors of protein kinases
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
